Back to Trades
Total Value
$0
Filing Date
Jul 17, 2026
1 transactions
Trade Summary
On Jul 15, 2026, Efron Paul, Director, reported $0 of Keenova Therapeutics plc (NONE) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Keenova Therapeutics plc
- Ticker Symbol
- NONE
- CIK
- 0001567892
Insider Information
- Name
- Efron Paul
- Role
- Director
- Location
- BRIDGEWATER, NJ
Filing Details
- Filing Date
- Jul 17, 2026
- Transaction Date
- Jul 15, 2026
- Accession Number
- 0001104659-26-084777
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 15, 2026 | NONE derivative | 4,406 | — | Grant/Award | — |
Want live alerts when Efron Paul trades again?
Download Insider Trades to track NONE, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Upon vesting, each restricted stock unit ("RSU") will be settled in ordinary shares of the Issuer at one share per RSU.
- (F2)The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders.